Fast hematopoietic recovery after bone marrow engraftment needs physiological proximity of stromal and stem cells

被引:13
作者
Janczewska, S
Wisniewski, M
Stepkowski, SM
Lukomska, B
机构
[1] Univ Texas, Sch Med, Div Immunol & Organ Transplantat, Dept Surg, Houston, TX 77030 USA
[2] Polish Acad Sci, Med Res Ctr, Surg Res & Transplantol Dept, Warsaw, Poland
关键词
hematopoiesis; bone marrow stromal cells; bone marrow transplantation;
D O I
10.3727/000000003108746948
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Relatively slow hematopoietic recovery after isolated bone marrow (I-BM) engraftment is probably caused by a disrupted microenvironment of stromal and stem cells. Thus, we compared the kinetics of hematopoietic recovery of lethally irradiated rats that received I-BM versus vascularized BM (V-BM). Total body irradiated (TBI; 8 Gy) Lewis (LEW; RT1(1)) rats were either injected IV with syngeneic sex-mismatched 80 x 10(6) I-BM or transplanted with 80 X 10(6) V-BM in orthotopic hind limb grafts. Ten days later, peripheral blood (PB) and mesenteric lymph nodes (MLN) of these recipients were examined for the presence of donor-derived hematopoietic cells with a panel of monoclonal antibodies by FACS. To detect male cells in sex-mismatched female recipients, PCR was performed using male Y chromosome primers. When examined in PB and MLN, recipients transplanted with V-BM displayed significantly faster recovery of leukocytes (CD43(+)), monocytes (CD14(+)), and T cells (CD5(+)) in comparison with I-BM recipients. In addition, only V-BM (but not I-BM) groups contained stroma-like male-positive cells in PB and MLN. Our results suggest that V-BM transplants provided superior hematopoietic recovery in comparison to I-BM transplants. We postulated that close proximity between stromal and stem cells in V-BM is essential for efficient repopulation with progenitors of different lines of leukocytes.
引用
收藏
页码:399 / 406
页数:8
相关论文
共 42 条
[1]   RECIPIENT ORIGIN OF BONE MARROW-DERIVED FIBROBLASTIC STROMAL CELLS DURING ALL PERIODS FOLLOWING BONE-MARROW TRANSPLANTATION IN HUMANS [J].
AGEMATSU, K ;
NAKAHORI, Y .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (03) :359-365
[2]   Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells [J].
Aoyama, K ;
Oritani, K ;
Yokota, T ;
Ishikawa, J ;
Nishiura, T ;
Miyake, K ;
Kanakura, Y ;
Tomiyama, Y ;
Kincade, PW ;
Matsuzawa, Y .
BLOOD, 1999, 93 (08) :2586-2594
[3]   ORIGIN OF MARROW STROMAL CELLS AND HEMATOPOIETIC CHIMERISM FOLLOWING BONE-MARROW TRANSPLANTATION DETERMINED BY INSITU HYBRIDIZATION [J].
ATHANASOU, NA ;
QUINN, J ;
BRENNER, MK ;
PRENTICE, HG ;
GRAHAM, A ;
TAYLOR, S ;
FLANNERY, D ;
MCGEE, JO .
BRITISH JOURNAL OF CANCER, 1990, 61 (03) :385-389
[4]  
Bertolini F, 1997, EXP HEMATOL, V25, P350
[5]   Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells [J].
Bhatia, M ;
Bonnet, D ;
Wu, DM ;
Murdoch, B ;
Wrana, J ;
Gallacher, L ;
Dick, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1139-1147
[6]   Marrow stromal stem cells [J].
Bianco, P ;
Robey, PG .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1663-1668
[7]  
BRUNO E, 1995, EXP HEMATOL, V23, P1212
[8]   Lymphocyte homing and homeostasis [J].
Butcher, EC ;
Picker, LJ .
SCIENCE, 1996, 272 (5258) :60-66
[9]   THE GROWTH-FACTOR REQUIREMENTS OF STRO-1-POSITIVE HUMAN BONE-MARROW STROMAL PRECURSORS UNDER SERUM-DEPRIVED CONDITIONS IN-VITRO [J].
GRONTHOS, S ;
SIMMONS, PJ .
BLOOD, 1995, 85 (04) :929-940
[10]   Drugs toxic to the bone marrow that target the stromal cells [J].
Guest, I ;
Uetrecht, J .
IMMUNOPHARMACOLOGY, 2000, 46 (02) :103-112